A phase 1 trial of CAR T-cell therapy in patients with folate-receptor positive osteosarcoma.

Trial Profile

A phase 1 trial of CAR T-cell therapy in patients with folate-receptor positive osteosarcoma.

Planning
Phase of Trial: Phase I

Latest Information Update: 10 Nov 2017

At a glance

  • Drugs CAR-T cell therapies (Primary)
  • Indications Osteosarcoma
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Nov 2017 New trial record
    • 06 Nov 2017 According to Endocyte media release, the IND filing of the drug is anticipated in 2018 and the initiation of trial is planned in 2nd half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top